MCU/MPH.to - Medicure - MC-1 Lead drug candidate for cardiovascular reperfusion is in PH 3 trial /w 3000 patients. Expect full enrollment Nov/07 with Data by August /08. This drug has zero side effects, zero competition, and No Partnership yet with Big Pharma as of 4/31/07.
since you know they won't have a partner at 4/31/07 can you also tell me what their stock price will be on that date. Better yet all stock prices and your answer doesn't have to be limited to life science stocks.
The data will be out way before August. That August date is probably when they would have their nda filed by
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.